The controls kit provides external positive and negative controls designed to assess the performance and reliability of the FebriDx® test in professional settings. Easy to store, simple to run, and aligned with CLIA and manufacturer recommendations, these controls help ensure your results remain accurate, reproducible, and compliant—test after test.

Features and Benefits:
Delivers results after 10 minutes
No equipment necessary
CLIA Waived Test

FebriDx® Rapid Respiratory Test is a rapid point-of-care test that differentiates bacterial infections from non-bacterial pathogens. In 10 minutes, this portable test allows medical providers to initiate the correct treatment and avoid the overuse of antibiotics.

Features and Benefits:

Allows medical providers to identify or rule out bacterial infections
Delivers results within 10 minutes
No equipment necessary
Reduces the need to write antibiotic prescriptions
99% Negative predictive value
CLIA Moderate Waived Test

A quick and practical point-of-care diagnostic test, the Healgen® COVID-19/Flu A&B Ag Combo Rapid Test Cassette (Dual Windows) can identify and distinguish COVID-19, Influenza A, and Influenza B from a single nose swab sample.

The test uses sophisticated lateral flow immunochromatographic technology and yields clear results in around 15 minutes, assisting medical practitioners in making prompt clinical decisions. Because the COVID-19 and Flu A/B detection areas are clearly separated, the dual-window design enhances result interpretation. The test facilitates quick screening during respiratory illness seasons when COVID-19 and flu symptoms frequently coexist, making it ideal for people who are experiencing symptoms.

The Healgen Combo Test is an effective option for clinics, healthcare facilities, and point-of-care testing settings because of its straightforward sample collection, dependable performance, and capacity to identify three common respiratory viruses simultaneously. Through rapid and precise respiratory virus testing, it facilitates diagnosis, enhances patient care, and supports infection control initiatives.

WELLlife™ SARS-CoV-2/Flu A+B Rapid Antigen Test is a POC rapid antigen test that detects SARS-CoV-2, influenza A, and influenza B in 10 minutes. This point-of-care immunoassay offers a broader detection window within five days of symptom onset.

The controls kit provides external positive and negative controls designed to assess the performance and reliability of the FebriDx® test in professional settings. Easy to store, simple to run, and aligned with CLIA and manufacturer recommendations, these controls help ensure your results remain accurate, reproducible, and compliant—test after test.

Features and Benefits:
Delivers results after 10 minutes
No equipment necessary
CLIA Waived Test